Publication | Closed Access

A Novel, Multi-Target Natural Drug Candidate, Matrine, Improves Cognitive Deficits in Alzheimer’s Disease Transgenic Mice by Inhibiting Aβ Aggregation and Blocking the RAGE/Aβ Axis

Rage/aβ AxisNeurodegenerative DiseasesAlzheimer's DiseaseAβ AggregationMedicineNeuropharmacologyCognitive DeficitsNeuroprotectionNeurologyNeuroscienceNeurodegenerationPharmacologyNeurochemistryProtective Mechanisms